Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Squamous Cell Carcinoma Antigen as a Marker of Sinonasal Inverted Papilloma

NCT01827423 is registered in ClinicalTrials.gov with University Hospital Ostrava as lead sponsor.

NCT NCT01827423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01827423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Squamous Cell Carcinoma Antigen as a Marker of Sinonasal Inverted Papilloma
Lead sponsor
University Hospital Ostrava
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2000
Completion date
January 31, 2012
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasal diseases, nasal polyps, papilloma